Briefly Noted

In “Guidance on Strategies to Promote Best Practice in Antipsychotic Prescribing for Children and Adolescents,” a 54‐page document from the federal Substance Abuse and Mental Health Services Administration (SAMHSA) released this spring, the federal government synthesizes the state of evidence in systems‐level strategies to promote antipsychotic best practice prescribing for young people. In response to safety concerns, federal, state, and public‐sector agencies have already invested in strategies to monitor prescribing and to support best practices. For Medicaid, since 2014 this is done by prior authorization, in which prescribing clinicians must receive approval for dispensing antipsychotic medications to youth. The document from SAMHSA is based on data collection and consensus building. Its goal is to provide a centralized resource for public‐ and private‐sector decision‐makers, prescribing clinicians, service providers, commercial insurance companies, and youth and their families. Identified strategies reviewed in this guidance include.